Is clinical target volume necessary for locally advanced non-small cell lung cancer treated with 4D-CT intensity-modulated radiation therapy
CTV omission was not suitable for stage III patients when the prescribed dose to PTV-g was 60 Gy in the era of 4D-CT IMRT. CTV omission plus high dose to PTV-g (74 Gy for example) warranted further exploration. The SIB-IMRT plan had the best protection to normal tissue including lymphocytes, and might be the optimal choice.
Authors
- Zewen Song (ORCID: https://orcid.org/0000-0002-9685-0725)
- Xu Tian (ORCID: https://orcid.org/0000-0003-3265-5725)
- Nan Xiang (ORCID: https://orcid.org/0000-0002-2283-1521)
- Weiwei Liang (ORCID: https://orcid.org/0000-0002-3637-4667)
- Jing Liang (ORCID: https://orcid.org/0000-0003-3252-7563)
- Jingsheng Zhao
- Guoyin Li (ORCID: https://orcid.org/0000-0002-9148-1051)
- Hui Xiang
- Wenxin Ding
Institutions
- Central South University (CN)
- Jishou University (CN)
- Zhengzhou University (CN)
- Henan Academy of Sciences (CN)
- Zhoukou Normal University (CN)
- Second Xiangya Hospital of Central South University (CN)
- Third Xiangya Hospital (CN)
- Shaanxi Normal University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1186/s12885-024-12979-z
- Citations
- 1
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- Xiangya Hospital, Central South University